CareForward Alliance

Americans should never have to worry about losing the right to choose, and that is exactly what @CMSGov 's decision does. The inclusion of urological and ostomy devices into the Competitive Bidding Program sets a dangerous precedent for the future of home health.

Patients deserve access to the individualized medical equipment that meets their needs. @CMSGov 's 2026 Home Health rule threatens that access for those who depend on urological and ostomy devices every day to live their lives with dignity. federalregister.gov/documents/2025…

Today’s decision by @CMSGov is deeply concerning for millions of Americans who rely on urological and ostomy devices. Read the full statement from CareForward Alliance here: careforwardalliance.org/statement-care…

@CMSGov shouldn’t expand a system that’s already failing patients. As @PacificResearch's Wayne Winegarden argued in Forbes in September, the competitive bidding model ignores individual medical needs—leading to infections and hospitalizations. We agree: Patients deserve personalized care, not one-size-fits-all policies. forbes.com/sites/waynewin…

The decision on competitive bidding is expected this week from @CMSGov — and millions of patients are at risk. 950,000+ Americans said no to limiting access to life-saving supplies. Will @CMSGov listen?

Time is ticking on the decision regarding the future of @MedicareGov's competitive bidding program. With patients, caregivers, and small medical device suppliers all at risk, members of Congress must speak out. The impact of this decision will be widely felt.

As @CMSGov eyes another round of “competitive bidding,” patients are the ones who’ll pay the price. Limiting access to innovative medical devices means more hospital stays and worse outcomes. Congress and CMS must stop this from happening.

Before expanding its reach, @CMSGov must fix the serious flaws in the competitive bidding system. Patients are facing severe risk, taxpayers are footing the bill, and accountability is nowhere to be found.

“When CMS forces these products into a bidding war, the result will not be smarter spending. It will be lower-quality products, reduced access, and unnecessary suffering.” Read more from Jim Martin @60PlusAssoc , in @WashTimes on competitive bidding’s flaws: washingtontimes.com/news/2025/oct/…

As Medicare beneficiaries and people with disabilities wait for a final decision on the rule change, @CMSGov should consider how these flaws will impact patients and taxpayers and look for another way forward.

It also emphasizes that the median bid encourages gamesmanship of lowball bids to hurt competition.

A new brief from @PacificResearch 's Center for Medical Economics and Innovation says that proposed reforms to the next round of competitive bidding don’t fix fundamental flaws. Read more: hmenews.com/article/think-…

Read more here: stripes.com/opinion/2025-1…

Expanding CMS’s Competitive Bidding Program is not just a threat to patients – it is a threat to American National Security. Former General James “Spider” Marks write in @StarsandStripes on the implications of this rule and how it hands China a strategic advantage over American manufacturing during a pivotal moment in U.S. – China relations.

Check out @hmeliz in @HME_News, where she highlights @CMSGov's latest expansion proposal as yet another way that the administration is threatening home-based care. hmenews.com/article/penny-…

Americans with disabilities and seniors on Medicare are deeply concerned about the impacts of competitive bidding if applied to urological and ostomy supplies. Disability advocates from across the country shared their stories: careforwardalliance.org/impact/

“The expansion of competitive bidding into these specialized product areas would undermine patient care and the integrity of the free market. CMS should withdraw this proposal and work with stakeholders to design policies that respect economic principles and serve patients — not bureaucratic efficiency.”

With a decision on the expansion of competitive bidding expected to come as early as October 31, alliance member @CASE_forAmerica urges CMS to keep individualized devices out of the program. dcjournal.com/when-competiti…

"CMS claims this move will cut costs and reduce fraud. But in practice, competitive bidding means reduced patient choice, jeopardized supply chains, and an incentive to push cheap, poorly made products that cause infections, sepsis, and lifelong health consequences."

Read about the need for choice from disability advocates like Ali in Stat News. Ali has been using catheters for 15 years, and knows that cheaper alternatives won't meet her medical needs. statnews.com/2025/10/21/cms…